You searched for: prostate type genomics
Prostate Genomics | Life Science Summit 2025
CEO Fredrik Rickman presents Prostatype Genomics at Life Science Summit 2025.
Prostatype Genomics lifts the lid on new product
Prostatype Genomics receives SEK 11,5 million from warrants
Prostatype Genomics takes the next step in the US – starts billing insurance companies
Since the second quarter of 2024, Prostatype has been used clinically by a growing number of urologists in the United States. The aim has been...
Prostatype Genomics updates on Medicare application
Prostatype Genomics begins invoicing in the US
Prostatype focuses commercialization through issuance
Prostatype Genomics' prognostic tool provides a more reliable risk classification in prostate cancer and a safer treatment decision for each patient, which...
Prostatype Genomics CEO on the commercialization strategy
In an interview, Prostatype Genomics CEO Fredrik Persson explains why the company's genetic test is needed for patients with confirmed prostate cancer. In addition...
Prostatype CEO: "Our US project is associated with low risks"
Prostatype Genomics is in the commercialization phase of its prostate cancer genetic test. The main focus is on the American market, where it...
BioStock Investor Pitch: Prostate Genomics
Prostatype Genomics has begun commercialization of its prognostic genetic test Prostatype for confirmed prostate cancer. Going forward, the company will aim to...
Prostatype's CEO on the commercial venture
Solna-based Prostatype Genomics has developed a diagnostic tool for assessing prostate cancer patients. The company is just at the start of its...
Prostatype bets on the US with an IPO
Prostatype Genomics had its commercial breakthrough last year. After hospitals reopened after the pandemic, the company was able to reap the...
BioStock Investor Pitch: Prostate Genomics
2022 was a breakthrough year for Prostatype Genomics, which was able to reap the first sales successes with its prostate cancer test. Now the company is investing...
Prostatype's CEO on US investment and issue
Solna-based Prostatype Genomics continues its transformation. From having a full focus on development, the company is now putting all its energy...
Top five life science stocks of the first quarter
Investors in the life science sector held tight to their wallets at the beginning of 2023. Only a few funding rounds were fully subscribed and...
Swedish innovations in the fight against prostate cancer
The month of November shines a spotlight on one of the most deadly cancers among men – prostate cancer. In this...
BioStock Studio: IPO-current Prostatype Genomics
On Wednesday, BioStock's studio was visited by IPO-prone Prostatype Genomics, which is currently conducting a new share issue that will provide the company with...
BioStock Live with Prostatype Genomics
Today, Wednesday, September 23 at 14:00 PM, it's time again for a live BioStock Live broadcast from BioStock's studio at...